Articles Related to Rheumatoid arthritis

Among patients with tuberculosis (TB), approximately 1 to 5 percent develop central nervous system (CNS) complications. A tuberculoma is a conglomerate granulomatous focus that develops from coalescing tubercles acquired during disseminated bacillaemia. Radiographically, tuberculomas are discrete, ring- enhancing lesions of the brain surrounded by perilesional edema and may present as single or multiple lesions. The diagnosis of tuberculoma should be suspected in patients with mass lesion of the brain and relevant epidemiologic factors. A definitive diagnosis of tuberculoma is established via needle biopsy of the CNS lesion for histopathology and acid-fast bacilli (AFB) staining and culture. In this case report, we present a 43-year-old woman with a past medical history of rheumatoid arthritis (RA) managed with steroids and hydroxychloroquine, who attended to us with a two- month history of numbness and paresthesia of her left extremities and recurrent episodic jerks involving the same side. Brain magnetic resonance imaging (MRI) revealed a large hemorrhagic mass (55 * 40 mm) in right temporo-parietal lobe surrounded by edema and mass effect with small nodule in left peri Rolandic cortex. Following clinical and laboratory clues, MR spectroscopy and brain biopsy, we started with corticosteroids and the following 4 anti-TB drugs: Isoniazid, Rifampin, Pyrazinamide, Ethambutol (HRZE). After 2 months, her symptoms completely resolved and a subsequent MRI scan revealed considerable shrinkage of the right-sided mass and left-sided lesion.

View complete article: PDF  |  Full-text

Introduction: Rheumatoid arthritis ( RA)is an autoimmune and inflammatory disease. It is characterized by arthrosynovitis with resultant joint destruction . So, an early clinical diagnosis along with simple serological tests like anti CCP antibodies, C –reactive protein ( CRP) and Rheumatoid factor (RF) play an important role .An attempt was made to study and compare these parameters in OPD and IPD RA patients in our hospital setup, VMMC and Safdarjung Hospital , New Delhi. Aims and Objectives: To study the role of RF , Anti-CCP antibodies and CRP in early detection and prognosis of Rheu- matoid arthritis. Materials and Methods: A Total of 440 samples were studied from January 2018 to December 2020 (3years). Correlation between Rheumatoid factor(RF) ,anti CCP antibodies and CRP in suspected RA patients from various departments like PMR , Orthopaedics , Medicine, Obstetrics and Gynaecology and Paediatrics was attempted. RF and CRP was performed using latex agglutination test and anti CCP antibody by ELISA. Results and Conclusion: Of 440 samples tested, all the factors were positive in 87 patients . Anti CCP and RF alone was seen in 32 patients. RF and CRP positive in 49 patients, RF alone in 22 patients. In 250 patients all the tests were negative. So, Anti CCP along with RF and CRP showed a better positive predictive value in patients of Rheumatoid arthritis. But positivity of these parameters even in patients who lack sign and symptoms also aids in better diagnosis, treatment and prognosis.

View complete article: PDF  |  Full-text

The present study evaluated the efficacy and safety of biosimilar infliximab in patients with active rheumatoid arthritis on a stable dose of methotrexate. Subjects were assigned randomly to either study infliximab or reference infliximab product in an approved dose of 3 mg/kg as an intravenous infusion at week 0, followed by similar doses at Weeks 2, 6 and 14. Primary efficacy endpoint was the proportion of subjects achieving ACR20 criteria at week 16 and secondary efficacy assessment included proportion of subjects achieving ACR20, ACR50 and ACR70 at week 16. In the open-label phase, all responders were followed till week 54. The non-responders entered a follow-up phase for immunogenicity and safety for an additional 3 months.

View complete article: PDF  |  Full-text

Introduction: Serum 14-3-3 eta provides diagnostic and prognostic information in Rheumatoid Arthritis (RA). It is coded by the YWHAH gene with single nucleotide polymorphisms (SNPs) linked to bipolar disorder and schizophrenia. It was hypothesized that 6 previously described YWHAH SNPs might relate to markers of RA disease severity such as seropositivity or erosive changes. Association study performed at an academic hospital Rheumatology Clinic. Subjects studied were 18 years of age or older with RA. TaqMan analysis screened for YWHAH SNPs rs2246704, rs2853884, rs3747158, rs4820059, rs7291050, rs933226. Primary endpoint was presence of at least one copy of the YWHAH SNPs with the markers of RA disease severity.

View complete article: PDF  |  Full-text

To verify the psoas major muscle (PMM) anatomical origin and variants, to evaluate the PMM attachment to the lumbar disc and variants, and to search for correlation between the anatomic variants of PMM attachment to the disc and disc extrusion.

View complete article: PDF  |  Full-text

Sjögren syndrome (SS) is chronic, systemic autoimmune disease characterized by lymphocytic infiltration of the exocrine glands. It is an elaborate involvement of the lacrimal and salivary glands, which eventually lead to keratoconjunctivitis sicca and xerostomia.

View complete article: PDF  |  Full-text

The C28/I2 line of immortalized juvenile human chondrocytes was employed to determine the extent to which recombinant human (rh) interleukin-6 (rhIL-6), the interleukin-6-like cytokine, rh-oncostatin M, and the adipokine, rh-adiponectin, activated extracellularsignal regulated kinase (ERK1/2), p38α mitogen-activated protein kinase (p38α MAPK) and c-Jun-amino-terminal kinase (JNK).

View complete article: PDF  |  Full-text

The current research in the field of drug delivery by which pulsatile release can be achieved has been intensified. The objective of the present study was to evaluate Luffa aegyptica mill powder as a novel superdisintegrant in the development of pulsatile drug delivery system (PDDS).

View complete article: PDF  |  Full-text

The objective of this study was to evaluate the encapsulation performance of Croscarmellose sodium, a superdisintegrant in a low-dose, poor-solubility drug formulation and the in-vitro dissolution performance of the Piroxicam capsules. Preparation, characterization and evaluation of the effects of the different concentrations of carmellose sodium and the amount of dried starch on in-vitro dissolution of Piroxicam capsules. Piroxicam was chosen for its very low solubility in biological fluids, which result in poor systemic bioavailability after oral administration. Piroxicam can be categorized as Class II drugs according to the Biopharmaceutics Classification System.

View complete article: PDF  |  Full-text